Telix Submits NDA for TLX101-CDx (Pixclara™) Brain Cancer Imaging Agent [Yahoo! Finance]
ASX LTD UNSP/ADR (ASXFY)
NASDAQ:AMEX Investor Relations:
asx.com.au/about/investor-relations.htm
Company Research
Source: Yahoo! Finance
a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-CDx, (Pixclara™ F-floretyrosine or F-FET), an investigational PET agent for the characterization of progressive or recurrent glioma (brain cancer) from treatment related changes in both adult and pediatric patients. Given the potential to address significant unmet medical need, Pixclara™ has been granted Orphan Drug and Fast Track designation by the FDA, which facilitates expedited review and closer consultation with the agency during the review process. FET PET (Pixclara™ ) is already included in international clinical practice guidelines for the imaging of gliomas , however there is currently no FDA-approved targeted amino acid PET agent for adult and pediatric brain cancer imaging commercially available in the U.S. There is a critical unmet need to improve the diagnosis and management of glioma, particularly in the post-treatment setting. With low survival rates and the need t
Show less
Read more
Impact Snapshot
Event Time:
ASXFY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASXFY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASXFY alerts
High impacting ASX LTD UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ASXFY
News
- Max Resource Provides Update on its Florália Hematite Iron Ore Project, Mina Gerais State, Brazil [Yahoo! Finance]Yahoo! Finance
- Institutional investors in ASX Limited (ASX:ASX) lost 5.0% last week but have reaped the benefits of longer-term growth [Yahoo! Finance]Yahoo! Finance
- CleanTech Lithium PLC Announces Interim Results [Yahoo! Finance]Yahoo! Finance
- Australia's Beston Global enters voluntary administration [Yahoo! Finance]Yahoo! Finance
- Our Pick Of The Best Oil Stocks For Australians [Forbes]Forbes